CRS Clinical Research Services Mannheim GmbH

CRS Clinical Research Services Mannheim focuses on heart‑related conditions, exploring new treatments to lower blood pressure and improve vascular health.

• Arterial hypertension studies
• Combination therapy safety assessments
• Drug‑drug interaction evaluations
• Blood pressure response monitoring

The site’s investigators collaborate with industry partners to evaluate novel agents that may reduce cardiovascular risk.

Research at the Mannheim clinic targets metabolic disorders such as Type 2 diabetes and obesity, aiming to improve glucose control and weight management.

• Glucose metabolism after mixed meal tolerance test
• Safety and tolerability of new antidiabetic agents
• Efficacy of combination treatments for overweight patients
• Impact of experimental drugs on insulin sensitivity

These trials assess how experimental drugs influence metabolic parameters in diverse patient groups.

The center conducts studies on immune challenges, including HIV‑1 infection and vaccine responses to tuberculosis, to enhance protective immunity.

• RNA‑based vaccine safety in healthy volunteers
• Antibody BNT351 biological activity assessment
• Immune response monitoring after vaccination
• Safety profiling in participants with and without HIV

By enrolling both healthy volunteers and affected individuals, the site evaluates safety and immunogenicity of cutting‑edge biologics.

Investigations address bacterial conditions like bacterial vaginosis, testing antiseptic and antibiotic strategies to restore healthy microbiota.

• Chlorhexidine vaginal antisepsis evaluation
• Oral metronidazole pre‑treatment study
• FB301 impact on vaginal microbiome composition
• Combined therapy effectiveness on symptom reduction

These projects seek to reduce recurrence rates and improve quality of life for women experiencing recurrent infections.

Trials examine chronic organ diseases, focusing on chronic liver disease and chronic kidney disease, to assess safety of herbal extracts and metabolic modulators.

• Silymarin‑standardized milk thistle extract safety
• MASLD (metabolic dysfunction‑associated steatotic liver disease) tolerability
• Renal function monitoring during novel therapy
• Biomarker analysis for disease progression

The research aims to identify therapies that can slow disease progression and support organ health.

Beyond defined therapeutic areas, CRS Clinical Research Services Mannheim conducts exploratory studies in healthy volunteers to understand drug absorption and interaction.

• Pharmacokinetic profiling of new compounds
• Food effect on drug bioavailability
• Combination formulation uptake assessment
• Safety monitoring in phase‑I healthy subject trials

These foundational investigations inform later disease‑specific trials and contribute to overall drug development knowledge.